Clinic
Southwest Cancer Care LLC
Southwest Cancer Care LLC was paid $1.29M by Medicaid between Aug 2019 and Dec 2024, across 24 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 24% of everything it billed.
33Billing provider infoSOUTHWEST CANCER CARE LLC
SIERRA VISTA, AZ 85635
SIERRA VISTA, AZ 85635
33aNPI1073007787assigned 06/15/2018
33bProvider typeOncology Clinic/Center
28Total paid$1.29M
24GClaims42,562
24DCodes billed24
24AFirst – last monthAug 2019 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 135 | $7K | |
| 2020 | 2,737 | $104K | |
| 2021 | 8,670 | $263K | |
| 2022 | 9,562 | $280K | |
| 2023 | 11,326 | $325K | |
| 2024incomplete | 10,132 | $313K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 5,426 | 4,890 | $315K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 21% | 3,661 | 3,175 | $275K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 14% | 4,769 | 1,935 | $180K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 9.5% | 1,935 | 904 | $123K |
| J3490 | Unclassified drugs | 8.3% | 5,128 | 1,460 | $107K |
| 96367 | 7.3% | 3,914 | 1,712 | $95K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 4.0% | 3,445 | 1,484 | $52K |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 2.8% | 122 | 84 | $36K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 1.9% | 1,462 | 485 | $25K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.8% | 2,928 | 1,477 | $24K |
| J1750 | Injection, iron dextran, 50 mg | 1.6% | 633 | 290 | $21K |
| 99195 | 1.1% | 186 | 164 | $14K |
12 more codes
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 424 | $11K |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | <1% | 344 | $5K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,673 | $4K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 3,506 | $2K |
| 96402 | <1% | 71 | $1K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,071 | $1K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 13 | $697.36 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 368 | $337.16 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 197 | $186.64 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 168 | $90.56 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 106 | $57.74 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 12 | $31.88 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSINDHU, HEMANT (PHYSICIAN / PARTNER)